Many of them already receive the bulk of their compensation in equity. So in the rare instances they do buy, it’s usually more about demonstrating their confidence in the business than making opportunistic financial bets.
And plenty of corporate insiders are selling -- even with the drops in equity indexes. Last week, George Yancopoulos, chief scientific officer of Regeneron Pharmaceuticals Inc., unloaded shares worth millions of dollars, while Microsoft Corp.’s Satya Nadella sold stock on March 3. Both transactions were part of scheduled trading programs.
This article was provided by Bloomberg News.